Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Basal Cell 3Pancreatic Neoplasms 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Telangiectasis 1Skin Neoplasms 1Rosacea 1Prostatic Neoplasms 1Precancerous Conditions 1Port-Wine Stain 1Pancreatic Intraductal Neoplasms 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nasopharyngeal Neoplasms 1Mixed Tumor, Malignant 1Melanoma 1Lung Neoplasms 1Keratosis, Seborrheic 1Keratosis 1Hemangioma 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma 1Barrett Esophagus 1

Interventions

Carboplatin 339Cisplatin 238Paclitaxel 203Radiotherapy 194Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 140Erlotinib Hydrochloride 107Etoposide 98Magnetic Resonance Spectroscopy 92Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 71durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49Irinotecan 42atezolizumab 41Topotecan 39Radiation 39Biopsy 39Cyclophosphamide 38Standard of Care 37Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Tomography, Optical Coherence × Clear all
NCT06556680 2024-08-27

EB-OCT Biopsy Guidance of Lung Cancer

Massachusetts General Hospital

Phase NA Not yet recruiting
200 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡